EP ELEDON PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 06 May 2025)
What this means for you
This application is over — abandoned 06 May 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90456181
- Mark type
- Word mark
- Filed
- 08 Jan 2021
- Published for opposition
- 08 Mar 2022
- Abandoned
- 06 May 2025
- Attorney of record
- Gregory B. Phillips
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products targeting selected biological pathways, namely, for the treatment of autoimmune and neurodegenerative diseases and for use in organ and cellular transplantation
- Class 042 — Scientific and technological services: Pharmaceutical research and development and medical research and development in the field of autoimmune and neurodegenerative diseases
Owner
- Eledon Pharmaceuticals, Inc., Irvine, CA, US
- Eledon Pharmaceuticals, Inc., Irvine, CA, US
Prosecution history
- 24 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2024 — SOU EXTENSION 5 GRANTED
- 22 Oct 2024 — SOU EXTENSION 5 FILED
- 22 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2024 — SOU EXTENSION 4 GRANTED
- 25 Apr 2024 — SOU EXTENSION 4 FILED
- 25 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2023 — SOU EXTENSION 3 GRANTED